ENDOXAN BAXTER for Plasma cell myeloma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 8 adverse event reports in the FDA FAERS database where ENDOXAN BAXTER was used for Plasma cell myeloma.
Most Reported Side Effects for ENDOXAN BAXTER
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 29 | 22.5% | 29 | 0 |
| Non-hodgkin's lymphoma | 12 | 9.3% | 12 | 1 |
| Disease progression | 11 | 8.5% | 0 | 0 |
| Exposure during pregnancy | 11 | 8.5% | 0 | 0 |
| Chronic graft versus host disease | 10 | 7.8% | 0 | 0 |
| Foetal exposure during pregnancy | 8 | 6.2% | 0 | 0 |
| No adverse event | 8 | 6.2% | 0 | 0 |
| Recurrent cancer | 8 | 6.2% | 0 | 0 |
| Plasma cell myeloma | 5 | 3.9% | 0 | 0 |
| Primary mediastinal large b-cell lymphoma recurrent | 5 | 3.9% | 0 | 0 |
Other Indications for ENDOXAN BAXTER
Stem cell transplant (27)
Hodgkin's disease (17)
B-cell lymphoma (14)
Bone marrow conditioning regimen (11)
Multiple sclerosis (11)
Foetal exposure timing unspecified (8)
Breast cancer (7)
Diffuse large b-cell lymphoma (7)
Non-hodgkin's lymphoma (7)
Primary mediastinal large b-cell lymphoma (5)
Other Drugs Used for Plasma cell myeloma
LENALIDOMIDE (273,951)
POMALIDOMIDE (81,096)
DEXAMETHASONE (49,067)
BORTEZOMIB (31,567)
DARATUMUMAB (19,119)
IXAZOMIB (17,602)
CARFILZOMIB (15,333)
THALIDOMIDE (10,689)
CYCLOPHOSPHAMIDE (9,148)
REVLIMID (7,122)